2024 PDA Visual Inspection Forum

The Patient is at the Center of our Vision!

Munich, Germany
Ask a Question Exhibitor Standard Contract Clause
Program Highlights

The agenda is out now!

Celebrate with us the 25th edition of this format!

This edition will be accompanied by a site visit at Körber Pharma Inspection in Markt Schwaben on 11 April 2024, where you can experience how it works out in practice.

Dear Colleagues,

On behalf of the Scientific Program Planning Committee and PDA Europe, we are looking forward to welcoming you to the 2024 PDA Visual Inspection Forum, to take place in Munich, Germany on 09-10 April 2024!

We are pleased to propose a Visual Inspection Forum that will be patient-centric.
The committee is planning another conference to keep you aware of recent advances in inspection technology and the ever-changing regulatory landscape.

Visual inspection, and especially the detection of particles, remains at the center of many discussions regarding product manufacturing control, quality assurance, and regulatory compliance. It provides a simple measure of process and product control to better assure the reliable delivery of high-quality medicines to the patients we serve. Recent GMP EU Annex 1 changes and FDA particle inspection draft guidance bring new perspectives to this visual inspection field.

Visual inspection methods and technology also continue to evolve. The application of artificial intelligence (AI) and deep learning (DL) to automated inspection is becoming a reality. Early adopter experience with these tools suggests potential improvements in inspection sensitivity and better avoidance of false rejection of good products. This, along with quicker method or recipe development should make this an important area for discussion and new learning. We will have experts working with these new tools speaking at this year’s forum to share their practical validation experiences.

Since 2000, we have organized the Visual Inspection Forum to discuss new technical and regulatory developments in this field. This annual meeting alternates between the United States and Europe and will be in Munich this year. We are pleased to have experts to discuss new developments in the field of visual inspection, including a basic understanding of the inspection process, special requirements for difficult-to-inspect products, particle characterization, practical aspects of manual and automated methods, and the regulatory and compendial requirements like those found in the update of Annex 1 or USP <1790>.

The forum program is intended to initiate and support discussion and professional exchange through the diversity of scientific presentations, poster sessions, training courses, and networking events.
We are celebrating the 25th Anniversary of the Visual Inspection Forum this year! Join us in Munich to see what’s new and how far we have come.

Sincerely,
The Co-Chairs

John Shabushnig, Insight Pharma
Romain Veillon, GSK

SCIENTIFIC PROGRAM PLANNING COMMITTEE:

  • John Shabushnig, Insight Pharma
  • Romain Veillon, GSK
  • John Ayres, Pharma Safety Solutions
  • Thorsten Daus, Vitronic
  • Rukman De Silva, US FDA
  • Markus Lankers, MIBIC
  • Hanns-Christian Mahler, ten23 health
  • Felix Riehn, Körber Pharma 
  • Djonny Rigot, Sanofi
  • Andrea Sardella, Stevanato Group
  • Herve Soukiassian, BD
  • Linda Wildling, Takeda
  • Jessie Lindner, PDA
  • Falk Klar, PDA Europe
  • Stefanie Nebelin, Senior Manager Programs & Events, PDA Europe

Networking Opportunities

Tuesday, 09 April 2024
Bräustüberl Weihenstephan

So, grab your Dirndl and Lederhosen, or whatever makes you feel comfortable, and join us for an evening of laughter, friendship, and coziness.

You are cordially invited to join us for an evening of networking at our Bavarian-themed dinner event! Get ready to don your finest Dirndl dresses and Lederhosen as we come together for an unforgettable night of connections and conviviality.

Indulge in a delectable spread of Bavarian specialties, including savory pretzels and refreshing beers. As you savor the flavors of Germany, take the opportunity to engage in meaningful conversations and forge valuable connections with fellow attendees.

A transfer to the venue will be provided.

We look forward to raising a glass with you in celebration of a successful networking event!

 

Featured Exhibitors
Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Standard Pricing

Standard Member Price

€ 2.250

GovernmentMember Only

€ 1.080

Health AuthorityMember Only

€ 1.080

Early Career ProfessionalMember Only

€ 1.080

StudentMember Only

€ 1.080

AcademicMember Only

€ 1.080

Non-Member

€ 2.550

See Qualifying Criteria for Member Types.

ALL PRICES IN EURO (EUR), EXCLUDING VAT.

WAYS TO REGISTER: 1. Online Registration   2. registration-europe@pda.org

PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact registration-europe@pda.org before registering.

If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.

Monday, 8 April CEST

15:00 – 18:00 | Registration Open

Tuesday, 9 April CEST

  • Registration Open

    Eventfoyer

  • Welcome and Introduction

    Room Ludwig-Alois

    • Committee Member: Falk Klar, PhD, Parenteral Drug Association

  • Welcome from the Co-Chairs

    Room Ludwig-Alois

    • Co-Chair: John G Shabushnig, PhD, Principal Consultant, Insight Pharma Consulting, LLC

    • Co-Chair: Romain Veillon, PharmD, Director Vision Technology MSAT, GSK

  • Opening Plenary: Particles: A Pharmacy and Regulatory Perspective

    Room Ludwig-Alois

    • Moderator: John G Shabushnig, PhD, Principal Consultant, Insight Pharma Consulting, LLC

    This session focuses on particles in parenteral drugs and how and where they are seen. It will provide both a new understanding of the size and types of particles that can be routinely detected during visible inspection and what is seen by pharmacists in clinical practice. It concludes with an update on current regulatory experience and expectations from the U.S. Food and Drug Administration.
    • Visible, Subvisible, and Microparticles in Parenteral Drugs – Facts and Figures in Daily Clinical Practice

      • Academic Presenter: Irene Kraemer, PhD, Director Department of Pharmacy, University Medical Center, Johannes Gutenberg-University Mainz

    • From Blur to Clarity: Definition of Particle Visibility Threshold in Parenteral Drug Products

      • Co-Presenter: Felix Nikels, Senior Principal Scientist, Boehringer Ingelheim

      • Co-Presenter: Atanas Koulov, PhD, Chief Scientific Officer, Clear Solutions Laboratories AG

    • Control of Visible Particulates in Injectable Pharmaceutical Products: A Life-Cycle Approach

      • Regulatory Presenter: Rukman S De Silva, PhD, Policy Lead, OPQ/OPPQ/CDER, U.S. FDA

    • Q&A, Discussion

      • Moderator: John G Shabushnig, PhD, Principal Consultant, Insight Pharma Consulting, LLC

      • Panelist: Irene Kraemer, PhD, Director Department of Pharmacy, University Medical Center, Johannes Gutenberg-University Mainz

      • Panelist: Felix Nikels, Senior Principal Scientist, Boehringer Ingelheim

      • Panelist: Atanas Koulov, PhD, Chief Scientific Officer, Clear Solutions Laboratories AG

      • Regulatory Panelist: Rukman S De Silva, PhD, Policy Lead, OPQ/OPPQ/CDER, U.S. FDA

  • Networking Coffee Break, Poster Session & Exhibition

    Eventfoyer

  • Session 1: Particle Identification and Life Cycle Case Studies

    Room Ludwig-Alois

    • Moderator: Markus Lankers, PhD, Managing Director, MIBIC GmbH & Co KG

    Understanding the source and composition of particulate matter provides the necessary substrate for the development of adequate control strategies and particle life cycle management. This session will discuss the development of analytical methods and tools for particle ID at manufacturing sites as well as a case study of the investigation of intrinsic particulates in early-stage development. Finally, the successful implementation of a visual inspection and particle life cycle management program will be highlighted.
    • Company-Wide Particle Life Cycle Management - A Success Story

      • Presenter: Antonio Burazer, Global Head of Visual Inspection & Particle LCM, Takeda Pharmaceuticals International AG

    • Investigation of Intrinsic Particulates in Sterile Solution: Case Study on Process vs Product Root Cause

      • Presenter: Valerie Pritiskutch, Lead Inspection Operator and Technologist, GSK

    • Identify Me – Particle Analysis at a Site Level

      • Presenter: Emily Beattie, Quality Technical Consultant- Global Quality Operations and Strategy, Baxter Healthcare

    • Q&A, Discussion

      • Moderator: Markus Lankers, PhD, Managing Director, MIBIC GmbH & Co KG

      • Panelist: Emily Beattie, Quality Technical Consultant- Global Quality Operations and Strategy, Baxter Healthcare

      • Panelist: Antonio Burazer, Global Head of Visual Inspection & Particle LCM, Takeda Pharmaceuticals International AG

      • Panelist: Valerie Pritiskutch, Lead Inspection Operator and Technologist, GSK

  • Networking Lunch Break, Poster Session & Exhibition

    Eventfoyer

  • Guided Poster Walk

    Eventfoyer

    • Moderator: Romain Veillon, PharmD, Director Vision Technology MSAT, GSK

    • Detection of defects in externally coated glass vials with automated visual inspection

      • Poster Presenter: Nico Spribille, Commercial Director Europe, Corning Inc.

    • Enhanced Test Methods for Visible Particle Detection & Enumeration on Elastomeric Closures and Glass Containers

      • Poster Presenter: Jahanvi Miller, MBA, Director of Quality, Amgen Inc.

    • Identify & Eliminate Sources of Visible Particles

      • Poster Presenter: Clay Foutch, Vice President of Sales, Foamtec International WCC

    • Probability of Detection Study

      • Poster Presenter: Menno Sels, MA, Process & Project Engineer, eyetec

    • Visual Inspection Program Development for a Frozen Oncolytic Virus Drug Product: Overcoming Challenges

      • Poster Presenter: Lynn Ward, MS, Senior Engineer, Process Development, Replimune

  • Interactive Questionnaire Session

    Room Ludwig-Alois

    • Moderator: Hanns-Christian Mahler, PhD, CEO (Chief Enablement Officer), ten23 health AG

  • Session 2: Visual Inspection Challenges for Difficult to Inspect Products

    Room Ludwig-Alois

    • Moderator: Andrea A Sardella, PhD, Product Development Manager, Stevanato Group

    Visual inspection has become a very well-established process that is key to warranty patient safety and product quality but there are still niche products that represent a challenge for implementing it effectively. In this session, we present some very interesting case studies focused on the inspection of difficult products like biologics or where presentation or container creates particular difficulties in the inspection process.
    • Visual Inspection and Particle Mitigation Approaches for Autologous Cell Therapies

      • Presenter: Pascal Chalus, PhD, Associate Director, Lonza AG

    • Attention to Detail – A Case Study on Particle Inspection in IV Bags

      • Co-Presenter: Thorsten Daus, Product manager, VITRONIC Dr.-Ing. Stein Bildverarbeitungssysteme GmbH

      • Co-Presenter: Rupert Gschwendtner, Head of R&D Medical, Kiefel GmbH

    • Visual Inspection of Small-Volume Parenteral Products

      • Presenter: Ragunath Ananthavettivelu, Director Visual Inspection & Device Assembly, ten23 health

    • Q&A, Discussion

      • Moderator: Andrea A Sardella, PhD, Product Development Manager, Stevanato Group

      • Panelist: Ragunath Ananthavettivelu, Director Visual Inspection & Device Assembly, ten23 health

      • Panelist: Pascal Chalus, PhD, Associate Director, Lonza AG

      • Panelist: Thorsten Daus, Product manager, VITRONIC Dr.-Ing. Stein Bildverarbeitungssysteme GmbH

      • Panelist: Rupert Gschwendtner, Head of R&D Medical, Kiefel GmbH

  • Networking Coffee Break, Poster Session & Exhibition

    Eventfoyer

  • Session 3: Manual Visual Inspection

    Room Ludwig-Alois

    • Moderator: Rukman S De Silva, PhD, Policy Lead, OPQ/OPPQ/CDER, U.S. FDA

    The purpose of this session was to discuss practical issues faced by people who work in the field of visual inspection. The discussion will include examples of current considerations for selecting statistical sampling and advancements of future direction for combined visual inspection applications for small drug product batches.
    • Counterintuitive Thinking: Why Accept on Zero Sampling Plans Allow MORE Defects to be Released

      • Presenter: Richard Monell, Principal Engineer, Baxter Healthcare

    • An Innovative Idea to Combine Visual Inspection with Compendial Method Testing

      • Co-Presenter: Susanne Gawenda, PhD, Senior Quality Control Expert, Analytical Science, Roche Diagnostics GmbH Mannheim

      • Co-Presenter: Andrea A Sardella, PhD, Product Development Manager, Stevanato Group

    • Q&A, Discussion

      • Moderator: Rukman S De Silva, PhD, Policy Lead, OPQ/OPPQ/CDER, U.S. FDA

      • Panelist: Susanne Gawenda, PhD, Senior Quality Control Expert, Analytical Science, Roche Diagnostics GmbH Mannheim

      • Panelist: Richard Monell, Principal Engineer, Baxter Healthcare

      • Panelist: Andrea A Sardella, PhD, Product Development Manager, Stevanato Group

  • End of Conference Day 1 & Networking Event

Wednesday, 10 April CEST

  • Registration Open

    Eventfoyer

  • Welcome to Day 2

    Room Ludwig-Alois

    • Co-Chair: John G Shabushnig, PhD, Principal Consultant, Insight Pharma Consulting, LLC

    • Co-Chair: Romain Veillon, PharmD, Director Vision Technology MSAT, GSK

  • Session 4: Automation in Visual Inspection & Artificial Intelligence

    Room Ludwig-Alois

    • Moderator: Romain Veillon, PharmD, Director Vision Technology MSAT, GSK

    New Automatic Visual Inspection equipment can deliver Deep Learning capacities that can now reach unmet performances in term of defect detection and false reject management. A.I. validation will require explainability to give transparency and trust to regulators. An example of ongoing deployment to production may inspire your organization.
    • Deep Learning for Enhanced AVI Detection Combined with Rule-Based Image Sequence Tracking for False Fail Reduction

      • Co-Presenter: Al Goodwin, B.Sc (Eng.) HDip, PRINCIPAL ENGINEER, AMGEN

      • Co-Presenter: Wolfgang Brandenburger, Dipl.-Ing., Data Scientist Inspection Systems Development, Körber Pharma

    • Navigating the Black Box: Monitoring and Explaining Deep Learning Models for AVI

      • Co-Presenter: Ioanna Psylla, MSc, Technical Product Owner, Novo Nordisk

      • Co-Presenter: Michal Stepien, MSc, OT Data Engineer, Novo Nordisk

    • Unlocking Potential: AI-Powered Visual Inspection in Commercial Use

      • Co-Presenter: Mario Holl, MSc, PhD, Managing Director, InspectifAI GmbH

      • Co-Presenter: Alessandra Corbisiero, Automation &CSV Manager, Patheon, by Thermo Fisher Scientific

    • Q&A, Discussion

      • Moderator: Romain Veillon, PharmD, Director Vision Technology MSAT, GSK

      • Panelist: Wolfgang Brandenburger, Dipl.-Ing., Data Scientist Inspection Systems Development, Körber Pharma

      • Panelist: Alessandra Corbisiero, Automation &CSV Manager, Patheon, by Thermo Fisher Scientific

      • Panelist: Al Goodwin, B.Sc (Eng.) HDip, PRINCIPAL ENGINEER, AMGEN

      • Panelist: Mario Holl, MSc, PhD, Managing Director, InspectifAI GmbH

      • Panelist: Ioanna Psylla, MSc, Technical Product Owner, Novo Nordisk

      • Panelist: Michal Stepien, MSc, OT Data Engineer, Novo Nordisk

  • Networking Coffee Break, Poster Session & Exhibition

    Eventfoyer

  • Session 5: Emerging Technologies for Visual Inspection

    Room Ludwig-Alois

    • Moderator: Linda Wildling, PhD, Head of Digital Innovation Success Management, Takeda Pharmaceuticals International AG

    As our reliance on technology continues to grow, it plays an increasingly crucial role in enhancing our daily lives and optimizing various operations. This session delves into the realm of emerging technologies, specifically focusing on their applications in visual inspection. Explore two groundbreaking examples that showcase how these innovative approaches are revolutionizing visual inspection within the pharmaceutical industry.
    • Reducing Inspection Complexity by Introducing Beyond-Human Sensing for Lyophilized Vaccine Inspection

      • Academic Presenter: Denise Tellbach, MA, PhD Candidate, Massachusetts Institute of Technology

    • Water Proton Nuclear Magnetic Resonance (wNMR) for Noninvasive Pharmaceutical Analysis

      • Academic Presenter: Bruce Yu, PhD, Professor, University of Maryland School of Pharmacy

    • Q&A, Discussion

      • Moderator: Linda Wildling, PhD, Head of Digital Innovation Success Management, Takeda Pharmaceuticals International AG

      • Panelist: Denise Tellbach, MA, PhD Candidate, Massachusetts Institute of Technology

      • Panelist: Bruce Yu, PhD, Professor, University of Maryland School of Pharmacy

  • Networking Lunch Break, Poster Session & Exhibition

    Eventfoyer

  • Interactive Questionnaire Session

    Room Ludwig-Alois

    • Moderator: Herve Soukiassian, Assoc. Director – Product Development, BD

  • Closing Plenary: Current and Future Perspective Part I

    Room Ludwig-Alois

    • Moderator: Herve Soukiassian, Assoc. Director – Product Development, BD

    This session will try humbly to reconcile the patient, the engineer, and the citizen...should the three be the same person. Starting with the current situation of the strategic Visual Inspection process, we'll then explore two potential forthcoming avenues. The first one will dive into the inevitable topic of data, and how to make sense of them beyond visual inspection itself. At the same time, the latter will share how the ecology of sense-making has contributed to serving sustainability ambitions in the microelectronic sector.
    • Highlights from the PDA Visual Inspection Survey 2023

      • Presenter: John G Shabushnig, PhD, Principal Consultant, Insight Pharma Consulting, LLC

    • Use Cases on Data Analytics to Increase Inspection Transparency and Machine Availability

      • Presenter: Felix Riehn, MSc, Head of Product Management, Körber Pharma

  • Networking Coffee Break, Poster Session & Exhibition

    Eventfoyer

  • Passport Raffle

    Room Ludwig-Alois

  • Closing Plenary: Current and Future Perspective Part II

    Room Ludwig-Alois

    • Moderator: Herve Soukiassian, Assoc. Director – Product Development, BD

    • Knowledge Management to Reach Challenging Sustainability Goals

      • Co-Presenter: Helene Vacelet, PhD, Sustainability Senior Program Manager, Becton Dickinson Pharmaceutical Systems

      • Co-Presenter: Stephane Hubac, Manufacturing Science Fellow, Retired From STMicroelectronics

    • Closing Panel Discussion

      • Moderator: Herve Soukiassian, Assoc. Director – Product Development, BD

      • Panelist: Antonio Burazer, Global Head of Visual Inspection & Particle LCM, Takeda Pharmaceuticals International AG

      • Regulatory Panelist: Rukman S De Silva, PhD, Policy Lead, OPQ/OPPQ/CDER, U.S. FDA

      • Panelist: Stephane Hubac, Manufacturing Science Fellow, Retired From STMicroelectronics

      • Panelist: Irene Kraemer, PhD, Director Department of Pharmacy, University Medical Center, Johannes Gutenberg-University Mainz

      • Panelist: Felix Riehn, MSc, Head of Product Management, Körber Pharma

      • Panelist: Helene Vacelet, PhD, Sustainability Senior Program Manager, Becton Dickinson Pharmaceutical Systems

  • Co-Chairs Conference Summary

    Room Ludwig-Alois

    • Co-Chair: John G Shabushnig, PhD, Principal Consultant, Insight Pharma Consulting, LLC

    • Co-Chair: Romain Veillon, PharmD, Director Vision Technology MSAT, GSK

  • Introduction to Site Visit at the Körber Pharma Facility

    Room Ludwig-Alois

    • Presenter: Rupert Depner, Dipl Ing, Area Sales Manager, Körber Pharma Inspection GmbH

  • Closing Remarks & Farewell

    Room Ludwig-Alois

    • Committee Member: Falk Klar, PhD, Parenteral Drug Association

Presenters

  • Ragunath Ananthavettivelu

    Director Visual Inspection & Device Assembly, ten23 health

    Panelist
    Presenter
    Read Bio
  • John D Ayres, MD

    Risk Assessment Clinician, Pharma Safety Solutions, LLC

    Committee Member
    Read Bio
  • Emily Beattie

    Quality Technical Consultant- Global Quality Operations and Strategy, Baxter Healthcare

    Panelist
    Presenter
    Read Bio
  • Wolfgang Brandenburger, Dipl.-Ing.

    Data Scientist Inspection Systems Development, Körber Pharma

    Co-Presenter
    Panelist
    Read Bio
  • Antonio Burazer

    Global Head of Visual Inspection & Particle LCM, Takeda Pharmaceuticals International AG

    Panelist
    Presenter
    Read Bio
  • Pascal Chalus, PhD

    Associate Director, Lonza AG

    Co-Presenter
    Panelist
    Presenter
    Read Bio
  • Alessandra Corbisiero

    Automation &CSV Manager, Patheon, by Thermo Fisher Scientific

    Co-Presenter
    Panelist
    Read Bio
  • Thorsten Daus

    Product manager, VITRONIC Dr.-Ing. Stein Bildverarbeitungssysteme GmbH

    Committee Member
    Co-Presenter
    Panelist
    Read Bio
  • Rukman S De Silva, PhD

    Policy Lead, OPQ/OPPQ/CDER, U.S. FDA

    Committee Member
    Moderator
    Panelist
    Regulatory Panelist
    Regulatory Presenter
    Read Bio
  • Melanie Decker

    Parenteral Drug Association

    Moderator
  • Rupert Depner, Dipl Ing

    Area Sales Manager, Körber Pharma Inspection GmbH

    Presenter
    Read Bio
  • Clay Foutch

    Vice President of Sales, Foamtec International WCC

    Poster Presenter
    Read Bio
  • Susanne Gawenda, PhD

    Senior Quality Control Expert, Analytical Science, Roche Diagnostics GmbH Mannheim

    Co-Presenter
    Panelist
    Read Bio
  • Al Goodwin, B.Sc (Eng.) HDip

    PRINCIPAL ENGINEER, AMGEN

    Co-Presenter
    Panelist
    Read Bio
  • Rupert Gschwendtner

    Head of R&D Medical, Kiefel GmbH

    Co-Presenter
    Panelist
    Read Bio
  • Mario Holl, MSc, PhD

    Managing Director, InspectifAI GmbH

    Co-Presenter
    Panelist
    Read Bio
  • Stephane Hubac

    Manufacturing Science Fellow, Retired From STMicroelectronics

    Co-Presenter
    Panelist
    Read Bio
  • Falk Klar, PhD

    Parenteral Drug Association

    Committee Member
    Read Bio
  • Atanas Koulov, PhD

    Chief Scientific Officer, Clear Solutions Laboratories AG

    Co-Presenter
    Panelist
    Read Bio
  • Irene Kraemer, PhD

    Director Department of Pharmacy, University Medical Center, Johannes Gutenberg-University Mainz

    Academic Presenter
    Panelist
    Read Bio
  • Markus Lankers, PhD

    Managing Director, MIBIC GmbH & Co KG

    Committee Member
    Moderator
    Read Bio
  • Hanns-Christian Mahler, PhD

    CEO (Chief Enablement Officer), ten23 health AG

    Committee Member
    Moderator
    Read Bio
  • Jahanvi Miller, MBA

    Director of Quality, Amgen Inc.

    Poster Presenter
    Read Bio
  • Richard Monell

    Principal Engineer, Baxter Healthcare

    Panelist
    Presenter
    Read Bio
  • Felix Nikels

    Senior Principal Scientist, Boehringer Ingelheim

    Co-Presenter
    Panelist
    Read Bio
  • Valerie Pritiskutch

    Lead Inspection Operator and Technologist, GSK

    Panelist
    Presenter
    Read Bio
  • Ioanna Psylla, MSc

    Technical Product Owner, Novo Nordisk

    Co-Presenter
    Panelist
    Read Bio
  • Felix Riehn, MSc

    Head of Product Management, Körber Pharma

    Committee Member
    Co-Presenter
    Panelist
    Presenter
    Read Bio
  • Djonny Rigot

    Global Quality Visual Inspection Expert, Sanofi

    Committee Member
    Read Bio
  • Andrea A Sardella, PhD

    Product Development Manager, Stevanato Group

    Committee Member
    Co-Presenter
    Moderator
    Panelist
    Read Bio
  • Christian A Scherer, Dipl.-Ing.

    Executive Vice President Sales, Körber Pharma

    Presenter
    Read Bio
  • Menno Sels, MA

    Process & Project Engineer, eyetec

    Poster Presenter
    Read Bio
  • John G Shabushnig, PhD

    Principal Consultant, Insight Pharma Consulting, LLC

    Co-Chair
    Moderator
    Presenter
    Read Bio
  • Herve Soukiassian

    Assoc. Director – Product Development, BD

    Committee Member
    Moderator
    Read Bio
  • Nico Spribille

    Commercial Director Europe, Corning Inc.

    Poster Presenter
    Read Bio
  • Michal Stepien, MSc

    OT Data Engineer, Novo Nordisk

    Co-Presenter
    Panelist
    Read Bio
  • Denise Tellbach, MA

    PhD Candidate, Massachusetts Institute of Technology

    Academic Presenter
    Panelist
    Read Bio
  • Helene Vacelet, PhD

    Sustainability Senior Program Manager, Becton Dickinson Pharmaceutical Systems

    Co-Presenter
    Panelist
    Read Bio
  • Romain Veillon, PharmD

    Director Vision Technology MSAT, GSK

    Co-Chair
    Moderator
    Read Bio
  • Lynn Ward, MS

    Senior Engineer, Process Development, Replimune

    Poster Presenter
    Read Bio
  • Linda Wildling, PhD

    Head of Digital Innovation Success Management, Takeda Pharmaceuticals International AG

    Committee Member
    Moderator
    Panelist
    Read Bio
  • Bruce Yu, PhD

    Professor, University of Maryland School of Pharmacy

    Academic Presenter
    Panelist
    Read Bio
  • Elizabeth Zybczynski, BS

    Senior Director, cGMP Systems, Baxter Healthcare

    Panelist
    Presenter
    Read Bio

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.

PDA Europe has reserved a limited number of rooms until 12 February 2024.
Please note that this special rate is subject to availability, as there is a city fair during this time.

To secure your room at the PDA Group Rate, please use the reservation button provided above.

How to Get Here
By Air

Take the S8 (direction Herrsching) from the airport to the Daglfing station and go from there about 3 minutes to the bus stop Daglfing station east. Ride the bus 183 until Paul-Henri-Spaak-Straße stop. The hotel is 100 meters away from the Paul-Henri-Spaak-Straße stop.

Unlock discounted pricing with the following code DEAPILE and simply use the provided link below.
By Car From the North : Drive on the A9, keep on the right, follow the signs to Salzburg / Österreich / Italien / Innsbruck and continue on the A99. At the exit München-Ost, keep on the right and take the A94 towards Munich. After approximately 6 km you exit the motorway at junction München-Riem and head left on the street “An der Point”, which changes into “Olof-Palme-Straße” after the second traffic light. The H4 Hotel München Messe is located on the right hand side after 500 m. The parking garage can be reached through the back of the hotel (Graf-zu-Castell-Straße). From the South: Drive on the A8 and at junction München-Süd continue on the A99 and follow the signs for Nürnberg / Stuttgart / Messe / München Flughafen. Change at junction München-Ost to the A94 and follow the signs to Munich. After approximately 6 km you exit the motorway at junction München-Riem and head left on the street “An der Point”, which changes into “Olof-Palme-Straße” after the second traffic light. The H4 Hotel München Messe is located on the right hand side after 500 m. The parking garage can be reached through the back of the hotel (Graf-zu-Castell-Straße).
By Other Options You can reach us by underground line 2 (towards Messestadt Ost, exit at Messestadt West). Or use the S-Bahn line 2 (towards Erding, exit at Riem) and afterwards take bus 190 (towards Messestadt Ost, exit at Am Messesee).